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ABSTRACT OF THESIS 
CAUSAL ATTRIBUTIONS AND SMOKING BEHAVIORS IN CERVICAL CANCER 
SURVIVORS: A MIXED-METHODS PILOT STUDY 
This cross-sectional, mixed-methods study examined the nature of, and 
association between, causal attributions and current smoking behavior in cervical cancer 
survivors who were smokers at cancer diagnosis (n=50). As a whole, participants’ beliefs 
about smoking as a risk factor or cause of cervical cancer in general (i.e., global 
attribution) and/or their own cervical cancer (i.e., personal attribution) reflected far 
greater endorsement of global than personal attributions. Data collection involved a 
quantitative survey and an optional semi-structured interview to assess key variables (i.e., 
smoking behavior and causal attributions). Data were analyzed via descriptive statistics 
and inferential tests, all of which illustrated greater endorsement of global smoking-
related causal attributions versus personal attributions within the sample. In conclusion, 
the results of this formative study highlights the potential role of causal attributions in 
understanding the smoking behavior of cervical cancer survivors, the results of which 
aids understanding of how cancer survivors think about, and make changes in, their 
smoking behavior. 
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Chapter One: Introduction 
Overview of Cervical Cancer 
In the United States, approximately 250,000 cervical cancer survivors are alive today, 
with an estimated 13,240 new cases projected for 2018 (American Cancer Society, 2018). 
The nationwide incidence rate of cervical cancer is 7.4 new cases per 100,000 women 
each year, and the mortality rate is 2.3 per 100,000 women (National Cancer Institute, 
2018). Nationally, cervical cancer deaths have decreased significantly over the past few 
decades due to more widespread adoption of Pap smear screening and human 
papillomavirus (HPV) vaccination (National Institute of Health, 2013). In some regions 
of the country, and for some populations, however, cervical cancer prevention and 
control have not evidenced any marked improvements (Freeman & Wingrove, 2005). To 
some extent, this is borne out in the state of Kentucky where the burden of cervical 
cancer remains high, as indicated by an incidence and mortality rate of 8.7 and 3.0 per 
100,000 women, respectively (National Cancer Institute, 2018), with an even higher 
incidence and mortality rate in the state’s Appalachian regions (10.2 and 3.2, 
respectively) (Hopenhayn, King, Christian, Huang, & Christian, 2008; Kentucky Cancer 
Registry, 2017). Despite the relatively small number of women who must cope with 
cervical cancer, this cancer should remain a key public health target because 1) it is one 
of the more preventable cancers (National Cervical Cancer Coalition, 2017) and 2) 
behavioral factors after cancer diagnosis can have a significant bearing on clinical 
outcomes and quality of life (National Cervical Cancer Coalition, 2017; US Department 
of Health and Human Services, 2014). 
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Cervical Cancer and Cigarette Smoking 
Cervical cancer risk is chiefly associated with HPV infection, but several other health 
behaviors and related factors play a role (e.g., obesity, smoking, long-term contraceptive 
use) (Stein & Colditz, 2004). Of all the behavioral factors associated with cervical cancer 
risk, probably none has as significant an effect on cervical cancer prognosis as smoking. 
Persistent smoking after cancer diagnosis carries considerable health risk, including 
increased risk for cancer and all-cause mortality, cancer recurrence, second primary 
cancer, and poorer response to and more complications after cancer treatment (US 
Department of Health and Human Services, 2014). The potential for negative outcomes 
among cervical cancer survivors in comparison to some other cancer survivors (e.g., 
prostate, breast, lung) may be particularly high because smoking can interact with HPV 
to increase recurrence risk (Burger et al., 1996), and as alluded to above, many cervical 
cancer survivors have HPV (Coker, DeSimone, Bush, Crofford, & Hopenhayn, 2009; 
Schiffman, Castle, Jeronimo, Rodriguez, & Wacholder, 2007). Finally, there are data to 
suggest that persistent smoking after cancer diagnosis is associated with worse quality of 
life (Blanchard, Courneya, & Stein, 2008; Browning, Wewers, Ferketich, Otterson, & 
Reynolds, 2009; Frumovitz et al., 2005; Piper, Kenford, Fiore, & Baker, 2012). 
Despite the clear clinical significance of the behavior, only a handful of studies have 
explored the prevalence of current smoking (or any other tobacco use) among cervical 
cancer survivors. This is likely due to the fact that cervical cancer is not viewed as a 
“smoking-related cancer” in the same way as lung or head/neck cancer, for example 
(American Cancer Society, 2018). That said, available data suggests the prevalence of 
current smoking among cervical cancer survivors is quite high, with estimates from US 
population-based and other large studies in the range of 40 to 50% (Brinton et al., 1986; 
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Coker, DeSimone, Eggleston, et al., 2009; Coups & Ostroff, 2005; D. K. Mayer & 
Carlson, 2011). In sum, the burden of cervical cancer can be compounded by the health 
risk behavior of persistent smoking, which can have a meaningful impact on the lives of 
cervical cancer survivors. 
Causal Attributions: Theories and Applications for Cancer 
Cancer has many causes, and it is often the case that the cause of any given cancer 
is unknown. Nonetheless, the beliefs that cancer survivors hold regarding what caused 
their cancer, or what causes cancer in general, can have a significant bearing on their 
health behavior performance and change. Several health behavior theories (namely, the 
Health Belief Model, Attribution Theory, and Theory of Planned Behavior) generally 
suggest that individuals who believe there are risks associated with their past or current 
behavior will try to adopt health-promoting behaviors – if they are sufficiently motivated 
to do so (Ajzen, 1991; Ajzen & Fishbein, 1980; Heider, 1958; Hochbaum, 1958; 
McBride, Emmons, & Lipkus, 2003; Weiner, 1985). Causal attribution models, in 
particular, explain that individuals who experience an unexpected negative event 
typically attempt to find a causal explanation for it, and then try to change their behavior 
and/or environment to prevent any future risks to their health or well-being (Hall, French, 
& Marteau, 2003). These models also suggest that individuals tend to categorize potential 
causes as either external (i.e., a situation, event, or stimulus outside one’s control) or 
internal (i.e., a trait or characteristic within the individual) (Ferrucci et al., 2011; Weiner, 
1985), a difference that is theorized to change the amount of responsibility, need for 
coping, and risk to self-concept experienced by the person (Callebaut, Molyneux, & 
Alexander, 2016). As it pertains to a negative health event like a cancer diagnosis, causal 
attributions may determine how individuals adjust to their illness and what steps they 
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take to promote their health (Callebaut et al., 2016; Ferrucci et al., 2011). 
Causal Attributions: Global versus Personal 
When asked to identify causes of, or risk factors for, cancer in general (i.e., global 
attributions), cancer survivors consistently identify genetics, other individual-level factors 
like smoking and obesity (Liang, Chen, & Giovannucci, 2009; Mullens, McCaul, 
Erickson, & Sandgren, 2003; Torre et al., 2015), and environmental factors (e.g., 
pollution, sun exposure, and second-hand smoke) (Ferrucci et al., 2011; Lykins et al., 
2008; Mullens et al., 2003; Rodriguez et al., 2015; Wold, Byers, Crane, & Ahnen, 2005). 
While cancer survivors’ global attributions usually have some degree of accuracy, the 
causal list typically generated is incomplete, as there is oftentimes little endorsement of 
physical inactivity (Gritz et al., 2006) and poor diet (Lykins et al., 2008) among other 
known risk factors for cancer. Also noteworthy is that while the majority of cancer risk 
stems from individual-level (and largely behavioral) factors (Willcox, Stewart, & Sitas, 
2011), environmental factors are reported at least as frequently as the former (Wold et al., 
2005). Overall, the literature on global attributions suggests there is still room for 
improvement when it comes to cancer survivors’ knowledge of what contributes to 
cancer. 
As mentioned above, cancer survivors can accurately identify some of the 
definitive causes of cancer in general; however, when asked to identify causes of their 
own cancer (i.e., personal attributions), the veracity of their beliefs is arguably less 
because stress and/or “God’s will” are often reported as some of the foremost causes 
(Costanzo, Lutgendorf, Bradley, Rose, & Anderson, 2005; Richman, Troutman, & 
Torres, 2016; Sterba, Zapka, LaPelle, Armeson, & Ford, 2015; Willcox et al., 2011; 
Wold et al., 2005). In samples of gynecologic cancer survivors, in particular, some of the 
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more well established causes of cancer are routinely linked more closely to cancer in 
general than to survivors’ own cancer (Costanzo et al., 2005; Stewart et al., 2001). For 
example, when asked about smoking, both current and former smokers agreed that 
smoking might have contributed to their cancer, but current smokers were more likely to 
believe that smoking was a greater risk factor for other people (Weinstein, Marcus, & 
Moser, 2005; Wold et al., 2005). It is possible that apparent disconnects like this are a 
form of self-protection, insofar as the admission of one’s role in causing one’s cancer 
could carry with it some negative effects (e.g., shame, guilt, despair). Nonetheless, the 
discordance between global and personal causal attributions creates a situation wherein 
cancer survivors may underestimate the clinical significance of their own health behavior 
change. 
Causal Attributions: Cervical Cancer and Smoking 
Many cervical cancer survivors lack knowledge about the causes of cervical 
cancer (Akinlotan et al., 2017; Low, Simon, Lyons, Romney-Alexander, & Waller, 
2012). Remarkably, cervical cancer survivors tend not to endorse smoking as a cause of 
cervical cancer, whether of their own cancer, or cancer in general. For example, one 
study found that gynecologic cancer survivors believe stress is a more powerful risk 
factor for cancer than smoking and several other known causal factors (Costanzo et al., 
2005). While only a handful of studies have looked at cervical cancer specifically, the 
consensus is that this population has high unmet need when it comes to health 
information (Brinton et al., 1986; Coker, DeSimone, Eggleston, et al., 2009; Collins, 
Rollason, Young, & Woodman, 2010; Costanzo et al., 2005; Marteau, Rana, & Kubba, 
2002; Plummer et al., 2003; Roura et al., 2014; Schlumbrecht, Sun, Huang, Zandstra, & 
Bodurka, 2014a). Unfortunately, healthcare providers often fail to educate their patients 
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about the robust benefits of health behavior change (Lindau et al., 2002; Mayer et al., 
2007; Underwood et al., 2012), including smoking cessation after cancer diagnosis 
(Warren, Sobus, & Gritz, 2014; Weaver et al., 2012). This missed opportunity undercuts 
efforts at secondary cancer prevention and general health promotion (Grimmett, Wardle, 
& Steptoe, 2009; Parsons, Daley, Begh, & Aveyard, 2010; Wold et al., 2005). 
Specifically, for cancer survivors who smoke, and particularly so for cervical cancer 
survivors, it is possible that fostering beliefs in smoking as a causal attribution could lead 
to efforts at smoking cessation, which if successful, could ultimately lead to measurable 
reductions in health risk and improvements in well-being. 
Study Aims and Hypotheses 
In a sample of cervical cancer survivors who were smokers at the time of their 
diagnosis, this mixed-methods pilot study first aims to describe, and then measure the 
relationship between, a) smoking-related causal attributions about cervical cancer and b) 
current smoking behavior. Regarding causal attributions, both global and personal causal 
attributions will be measured, as a first step to determining if participants believe the 
cause of their cervical cancer is similar to or different from the cause of other women’s 
cervical cancer. Regarding smoking behavior, several outcomes will be considered 
including overall prevalence of current smoking, frequency and amount of smoking, and 
motivation to quit/abstain from smoking. All analyses for the first aim (i.e., to describe 
causal attributions and smoking behavior) will be descriptive in nature, with use of both 
qualitative and quantitative data. In contrast, analyses for the second aim (i.e., to measure 
the relationship between causal attributions and smoking behavior) will include 
inferential tests of pertinent quantitative data plus content analysis of qualitative data. In 
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sum, the mixed-method study design lends itself to use to complementary and 
simultaneous use of qualitative and quantitative data analysis. 
8 
Chapter Two: Methods 
Participants and Procedure 
Population and Eligibility. Participants were 50 cervical cancer survivors 
currently living in the state of Kentucky who were diagnosed with a first primary cervical 
cancer in the past five years. Additional eligibility criteria were: 1) Kentucky residence at 
diagnosis, 2) age over 21 at the time of enrollment, 3) English literacy and fluency, 4) 
diagnosis between the age of 21 and 55, 5) lifetime smoking history (i.e., having smoked 
more than 100 cigarettes), 6) smoking at diagnosis according to a 3-month point 
prevalence definition, 7) reliable phone access, 8) not being pregnant or planning to 
become pregnant in the 6 months following enrollment, 9) having no cognitive or 
psychological impairments or diagnoses, and 10) no prior cancer diagnoses (excluding 
melanoma). 
Recruitment and Enrollment. Participants were recruited through a combination of 
population sampling (Kentucky Cancer Registry, KCR) and purposive sampling 
(Kentucky Cancer Link, KCL). KCR is a statewide, population-based cancer registry that 
is part of the Surveillance Epidemiology and End Results (SEER) system and the CDC’s 
National Program of Cancer Registries. KCL is a statewide organization that provides 
access to cancer-related screening, services, and support (e.g. mastectomy garments, 
wigs, patient navigation, transportation, smoking cessation classes) to low-resource 
residents in Kentucky, that is, uninsured or underinsured adults who fall below the 
Federal Poverty Line (Kentucky Cancer Link, 2017). The use of both KCR and KCL was 
intended to produce a sample of cervical cancer survivors who were representative of the 
population at the state level and who would benefit most from future resource 
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dissemination related to smoking cessation (Adler et al., 1994; Coups & Ostroff, 2005; 
Ward et al., 2010). 
Potentially eligible cervical cancer survivors (i.e., those who had a documented 
lifetime history of tobacco use and Kentucky residence at diagnosis) were given the 
opportunity to opt-in to study participation through invitations sent directly by 
KCR/KCL. At this stage of recruitment, cancer survivors were informed that they might 
be eligible to participate in a research study, but only a very brief description of the study 
was provided. For KCR, the first step involved physician notification and attainment of 
his or her approval to contact the cancer survivors. If warranted, the second step involved 
cancer survivor notification, where cancer survivors were asked to indicate whether or 
not they approve of their contact information being released to study staff. At this step, 
cancer survivors were contacted by mail and/or phone in order to gain their approval. For 
KCL, the same approach was used, but cancer survivors were contacted directly without 
physician involvement. In the case of both KCR and KCL, a research assistant only 
attempted to contact cancer survivors who “opted in” to study consideration. 
Once research assistants received the names and contact info for all cancer 
survivors who “opted in,” they attempted to contact them via phone to screen them for 
eligibility. Ineligible cancer survivors were thanked for their time and not contacted 
further. Eligible cancer survivors were informed about the study in greater depth and 
asked if they would like to participate. If eligible and interested, an attempt was made to 
enroll cancer survivors into the study via attainment of written informed consent. Once 
enrolled into the study, the procedures for data collection commenced. In cases where 
cancer survivors were not reached via phone, research assistants tried to reach them via 
mail and engage them in study participation via that route. 
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Data Collection. Data collection consisted of two parts. First, a standardized 
questionnaire was completed either via a phone interview with a research assistant or a 
mailed paper-and-pencil form. For both methods of data collection, de-identified data 
were entered and stored securely in a REDCap database to preserve participant privacy 
and confidentiality. Second, participants were invited to complete a brief semi-structured 
interview via phone, an opportunity for them to explain their experiences of smoking (or 
quitting) after cervical cancer in their own words. A standardized interview guide was 
used, with the nature and number of follow-up or “targeted” questions tailored to each 
participant’s response to the core set of open-ended questions (Hsieh & Shannon, 2005). 
Interview data were recorded and transcribed verbatim, with all relevant files de-
identified to preserve participant privacy and confidentiality. The questionnaire took 
approximately 35 minutes to complete, and the interview generally lasted 25 minutes. 
Compensation. Participants were compensated $45 for questionnaire and $30 
interview completion. Payments were made via check mailed to participants’ home 
address. 
Ethical Approval. All procedures were reviewed and approved in advance of 
implementation by the University of Kentucky Institutional Review Board and Markey 
Cancer Center Protocol Review and Monitoring Committee. 
Measures 
Demographics. Standard items were used to assess participants’ demographic 
background (e.g., age, race, relationship status, education level). Items were primarily 
taken from a recent Behavioral Risk Factors Surveillance System survey (Centers for 
Disease Control and Prevention, 2015), a yearly population-based health survey of non-
institutionalized adults in the United States. 
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Clinical History. KCR provided the following pieces of information about each 
participant: time since cancer diagnosis, age at diagnosis, site and stage of cancer 
diagnosis, type of treatment, recurrence status, and insurance status. 
Causal Attributions. Causal attributions about cervical cancer were measured 
from both a global and personal perspective, all with a focus on smoking as an etiological 
factor. First, two items on the questionnaire tap causal attributions. One item from the 
Cervical Cancer Objective Test (Ralston et al., 2003) was used to assess global 
attributions of cervical cancer: “The risk of developing cervical cancer is higher if 
someone is a smoker”. Participants were asked to indicate whether this statement is false 
(0) or true (1). Similarly, one item from the Perceived Cancer Related Stigma Scale 
(LoConte, Else-Quest, Eickhoff, Hyde, & Schiller, 2008) was modified to measure 
personal attributions of cervical cancer: “My smoking or other tobacco use contributed to 
my cancer”. Participants responded to this item on a Likert scale from 1=strongly 
disagree to 5=strongly agree, which was later dichotomized to reflect disagreement (0) or 
agreement (1). Second, causal attributions were measured through interview questions 
about the extent to which participants believe smoking impacts cervical cancer (e.g., 
“What role, if any, do you believe that smoking has in cervical cancer?”). 
Smoking Behavior. Smoking behavior was measured via a combination of 
questions that are regularly used in research with the general population of smokers (Bolt 
et al., 2009; Centers for Disease Control and Prevention, 2015; Heatherton, Kozlowski, 
Frecker, & Fagerstrom, 1991) and specifically among cancer survivors (Land et al., 
2016). In the questionnaire, smoking behavior was assessed in a comprehensive fashion. 
First, 30-day and 7-day point prevalence of current smoking were determined at the 
sample level. Second, and only among current smokers, the frequency (i.e., how often) 
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and amount (e.g., average number of cigarettes per day in the past week as reported via 
time-line follow-back) of smoking and level of nicotine dependence (as measured by the 
Heaviness of Smoking Index (Heatherton et al., 1991) were explored, among other 
things. Additionally, in the full sample, several components of quit behavior were 
examined, including: 1) motivation and confidence to quit or maintain abstinence over 
the next 30 days, as measured on a scale from 0=very definitely no to 10=very definitely 
yes; 2) prevalence and number of 24-hour quit attempts since cancer diagnosis; and 3) use 
of smoking cessation treatment since cancer diagnosis. In the interview, smoking and quit 
behavior were measured (e.g., “How much and how often did you smoke before and after 
your diagnosis?” and “What approaches did you use to quit or cut back?”). 
Data Analysis 
Data analysis employed use of quantitative and qualitative methods for the questionnaire 
and interview data, respectively. First, for the questionnaire data, descriptive statistics 
(e.g., prevalence, frequency, mean, standard deviation) were used to determine the extent 
of endorsement of smoking as a cause of cervical cancer on global and personal levels. 
These same statistics were used to describe thoroughly the sample’s smoking (i.e., 
prevalence, frequency, amount, and motivation to quit/abstain) and quit (i.e., prevalence, 
number, and method of quit attempts post-cervical cancer diagnosis) behavior. 
Additionally, chi-square (2) and bivariate correlation (Spearman’s rho) analyses of 
questionnaire data were performed as an initial test of the association between causal 
attributions and smoking behavior. Second, interview responses that address the issue of 
causal attributions, smoking and other tobacco use status, and the link between these 
variables were explored. These analyses involved directed content analysis (Hsieh & 
Shannon, 2005), where prior research and theories pertinent to causal attributions helped 
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guide analysis. This analysis involved many steps: 1) reading, re-reading, and then 
discussing with several co-investigators a random selection of interviews (n=7); 2) 
identifying key concepts or variables as initial codes; 3) organizing the initial codes into a 
draft codebook (see Table 1) and creating operational definitions for each code; 4) 
double-coding (i.e., independent coding by two individuals, with discrepancies among 
codes discussed and rectified to achieve a “final” set of agreed upon codes for each 
interview) the aforementioned interviews via line-by-line coding (Charmaz, 2006); 5) 
finalizing the codebook, which involved hierarchical organization with “lumping” or 
“splitting” some of the initial codes and adding new codes; 6) revising the previously 
coded interviews (n=7) to reflect the final codebook; 7) double-coding all remaining 
interviews (n=14) consistent with the final codebook; and 8) entering and analyzing all 
coded interviews (n=21) in ATLAS.ti version 8 (Berlin, Germany). 
Table 1 
Codebook for qualitative data analysis: Smoking-related causal attributions of cancer 
Variable/Code Operational Definition Illustrative Quotes 
Smoking Causes Cancer in General – Global Casual Attributions 
Smoking directly caused, or is a significant risk 
factor for… 
…Cervical cancer
…Head, neck, or lung cancer
…Any type of cancer
Yes, it does “I know that, you know, smoking does cause 
cancer.” (148) 
Maybe, it’s possible “I really didn’t correlate the whole smokin’ and 
cancer…but it’s hit home a little bit more.” (100) 
No, it doesn’t “I don’t think smoking’s got anything to do with 
any type of cancer, in my personal opinion.” (106) 
I don’t know “I really can’t say yes on that one, ‘cause I really 
don’t know if it would be or not.” (120) 
Smoking Caused My Cervical Cancer – Personal Casual Attributions 
Smoking directly caused, or is a significant risk 
factor for participant’s own cervical cancer 
Yes, it did “I’ve only heard that it’s not good to smoke…that 
that’s one of the causes…so I knew that was 
another, you know, thing that wasn’t very good 
for it.” (143) 
Maybe, it’s possible “I’m still not sure that it had anything to do 
with the cervical cancer, but I don’t know. 
That’s a possibility.” (137) 
No, it didn’t “I don’t believe it had any role as far as the 
cervical cancer.” (142) 
I don’t know “Maybe it’s because I did smoke, I don’t smoke.” 
(127) 
Smoking Status - Current 
Former smoker who quit at one point after cancer 
diagnosis and never smoked again 
Former, with continuous 
abstinence 
“Last year I went through cervical cancer. I 
stopped smokin’ and stopped drinkin’.” (149) 
Former smoker who quit at one point after cancer 
diagnosis, but smoked a handful of times 
Former, with lapses “I couldn’t even tell you how long it’s been since 
I had a cigarette, it’s been so long.” (100) 
Current smoker who made 4 or more QA1 after 
cervical cancer diagnosis 
Smoker, with many QA “I’d like to try to quit smoking. I’ve tried so 
many times, it’s just nothing works!” (120) 
Current smoker who made 1-3 QA after cervical 
cancer diagnosis 
Smoker, with a few QA “I went back to smokin’, but it was like a while 
after the treatment.” (152) 
Current smoker who made 0 QA after cervical 
cancer diagnosis 
Smoker, with no QA “I think I smoke probably more now that I did 
before and that’s crazy! Because you think I 
would wanna quit.” (127) 
Note: QA= Quit attempt1. Options are mutually exclusive. 
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Chapter Three: Results 
Sample Accrual 
The details of accrual can be found in Figure 1. As shown, KCR and KCL 
identified 268 and 48 potentially eligible survivors, respectively. Of those identified by 
KCR, 34.3% (n=92) consented to study contact, 60.6% (n=63) of whom were 
successfully reached and screened. Of those screened, 71.4% (n=45) met eligibility 
criteria, with the most common reason for ineligibility being denial of tobacco use at 
diagnosis. Finally, the enrollment rate of those eligible was 91.1% (n=41). Of those 
identified by KCL, 50.0% (n=24) consented to study contact, 70.8% (n=17) of which 
were successfully reached and screened. Of those screened, 76.5% (n=13) met eligibility 
criteria, with the only reason for ineligibility being a denial of tobacco use at diagnosis. 
Finally, the enrollment rate of those eligible was 92.3% (n=12). In total, 53 individuals 
enrolled in the study, but 5.7% (n=3) were lost to follow-up, which means they provided 
written informed consent but did not furnish any study data. Therefore, our final sample 
consists of 50 cervical cancer survivors. 
Sample Characteristics 
Demographic Variables. A clear majority (94.0%, n=47) of this entirely female 
sample was White, non-Hispanic. On average, participants were 45.5 (SD=8.1) years old. 
Roughly half of participants were in a relationship (46.0%, n=23), but many self-
identified as divorced (20.0%, n=10) or separated (10.0%, n=5). Many participants 
reported having less than a high school education (38.0%, n=19), with very few having 
completed a college degree (8.0%, n=4). Nearly two-thirds of participants were 
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unemployed (64.0%, n=32), and related to that, roughly half of their annual household 
income fell under $20,000 per year (54.0%, n=27). Finally, a majority of participants 
indicated rural or Appalachian residence at the time of study participation (60.0%, n=30). 
More details about participants’ demographic characteristics can be found in Table 2. 
Clinical Variables. The average age at diagnosis was 42.8 (SD=8.0) years old, 
with the average time since diagnosis being 2.7 years (SD=1.3). Stage of cancer at 
diagnosis spanned from Stage I (56.0%, n=28) to Stage IV (2.0%, n=1). Many 
participants received multimodal treatment (60.0%, n=30), with the most common 
treatment regimen among these patients consisting of surgery, radiation, and 
chemotherapy (30.0%, n=15). At the time of recruitment, 68.0% (n=34) of the sample 
was disease-free. Very few (6.0%, n=3) participants reported an absence of insurance 
coverage; the most common coverage was Medicaid (48.0%, n=24). More details about 
the clinical composition of the sample are available in Table 3. 
Aim 1: Causal Attributions 
This study involves a description of smoking-related causal attributions among cervical 
cancer survivors who smoked at diagnosis. Data on participants’ causal attributions are 
pulled from both the questionnaire and interview, and the next two sections reflect 
analysis of each of these aspects of this mixed-methods pilot study. 
Questionnaire Results. Sixty-four percent (n=32) of participants agreed with a statement 
about the risk of developing cervical cancer being higher if someone is a smoker. This 
would suggest many of the cervical cancer survivors in this study conceptualize smoking 
as a risk factor for, or cause of, cervical cancer in general. However, when asked about 
the extent to which they believed their smoking (or other tobacco use) contributed to 
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their cervical cancer, only 28.0% (n=14) “agreed” or “strongly agreed.” Given the 
different levels of endorsement between global and personal attributions as they pertain 
to smoking and cervical cancer, crosstab analyses were run to explore further these 
outcomes. Thirty-four percent (n=17) of the sample endorsed neither global nor personal 
attributions, 26.0% (n=13) endorsed both global and personal attributions, and the 
remainder endorsed global attributions alone (38.0%, n=19) or personal attributions alone 
(2.0%, n=1). 
Interview Findings. Participants who completed the interview (n=21) responded to this 
open-ended question: “What role, if any, do you believe that smoking has in cervical 
cancer?”. The most common response to this question reflected participants being 
completely unaware or unsure of the causal link between smoking and cervical cancer in 
general (i.e., global attributions): 
“You know, I really don’t know. I mean, I thought the 
reason why I got the cervical cancer because I had the 
HPV virus. They said that some, most women get it, but it 
normally will just go away, ‘cause the body fights it and I 
guess mine didn’t. And maybe that’s because I did smoke, 
I don’t know.” (127) 
“I don’t know if, I don’t know if it even plays a role in 
it. I’m not sure.” (137) 
“Well, nobody had ever really told me anything about it 
at all, about they go hand-in-hand or nothin’.” (144) 
In comparison to the more common endorsement of uncertainty, a clear minority of 
participants firmly believed smoking to be associated with cervical cancer risk in general, 
while some participants remarked that smoking has no association with cervical cancer: 
For example, one participant said, “It plays a big part. I didn’t start smoking until I was 
thirty. And when I found out that I had cervical cancer, the doctor told me to stop 
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smokin’.” (149), while others made comments like “I don’t believe it plays any [role] in 
cervical cancer” (142) and “there’s so many people that get cancer who never smoked or 
anything, so I don’t really think it’s linked to smoking.” (126). Participants’ 
understanding of the association between smoking and cervical cancer was in stark 
contrast to their comments about the connection between smoking and “traditional” 
smoking-related cancers like lung and oral cavity cancer, or the risks of smoking for 
health in general. 
“I mean, it does [have to do] with lung cancer and throat 
cancer, but cervical cancer? No.” (137) 
“I don’t believe it plays any [role] in cervical cancer…now 
lung cancer, something like that…is a different story” (142) 
“Cigarettes are known to cause cancer anyways…so if it is, 
it’s probably not cervical cancer. It’s probably lung cancer 
or somethin’ like that, I don’t know.” (156) 
“With all the, you know, negative effects that smoking can 
have on people. I mean, not just cancer, but you know, 
heart disease, emphysema, I mean…you’d be crazy to pick 
up a cigarette and smoke.” (148) 
In terms of participants’ causal attributions about their own cervical cancer (i.e., personal 
attributions), few spoke in a manner that suggested their smoking might have a role in 
their cancer diagnosis. As examples of personal attributions, one participant said, “I got 
cervical cancer, and I smoked, and I’m still smoking. It was a huge part.” (121). 
Similarly, “I felt guilty every time I lit a cigarette up after I knew I had cancer, because I 
knew that it contributed to the cancer” (108). The more common responses to questions 
of personal attributions reflected either uncertainty or disbelief that smoking caused or 
increased risk related to their personal cancer experience. One participant said, “I don’t 
even know how it really came about, you know? …That’s the one thing I never really 
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found out” (152), with another saying, “I don’t think that I would have to worry about 
catchin’ cervical cancer again…smoking causes a lot of different stuff but didn’t have 
nothin’ to do with any of that” (131). In sum, participants’ global and personal 
attributions as measured via interview reflect great diversity of opinion. 
Aim 1: Smoking and Other Tobacco Use Behavior 
This study also involves a description of the tobacco use behavior of cervical cancer 
survivors who smoked at diagnosis. Data on participants’ smoking and non-cigarette 
tobacco use reflect questionnaire and interview responses alike while all other smoking-
related outcomes (e.g., motivation to quit/abstain) are confined to questionnaire data. 
Questionnaire Results for Smoking Behavior. Consistent with inclusion criteria, all 
participants endorsed a lifetime history of cigarette smoking, which was defined as ever 
having smoked at least 5 packs or 100 cigarettes in total. In addition, and also a 
consequence of the inclusion criteria, all participants reported smoking within the month 
prior to their cervical cancer diagnosis. In terms of current smoking behavior as measured 
via questionnaire, the 30-day point prevalence rate of smoking was 79.5% (n=39/49 
respondents), which is very similar to, but not exactly the same as the 7-day point 
prevalence rate of smoking (77.1%, n=37/48 respondents). When asked the precise 
number of days they smoked in the past 30 days, participants’ responses ranged from 0 
(22.0%, n=11) to 30 (62.0%, n=31), with daily smoking being the modal response. In 
sum, at the time of study participation, the clear majority of the sample could be 
described as regular smokers. Current smokers reported smoking an average of 16.5 
(SD=8.7) cigarettes per day, and nearly three-quarters reported smoking their first 
cigarette of the day within 30 minutes of waking (71.0%, n=27). Based on the Heaviness 
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of Smoking Inventory (Heatherton et al., 1991), the average level of nicotine dependence 
among current smokers was 2.7 (SD=1.5), which falls into the moderate range. 
Questionnaire Results for Non-Cigarette Tobacco Use. Roughly half of those who 
reported a 30-day point prevalence of cigarette smoking (i.e., “current” smokers) also 
reported a 30-day point prevalence of non-cigarette tobacco use (43.6%, n=17). The 
nature of smokers’ dual tobacco use (or in some cases multi-tobacco product use) was as 
follows: 15.4% (n=6) electronic cigarettes; 12.8% (n=5) cigars or pipes; 2.6% (n=1) 
chewing tobacco or moist snuff; 2.6% (n=1) Swedish-style snus; options not mutually 
exclusive. It should also be noted that while none of the former smokers reported a 30-
day point prevalence of non-cigarette tobacco use, a minority did endorse a lifetime 
history of non-cigarette tobacco use (18.2 %, n=2). 
Interview Findings on Smoking and Non-Cigarette Tobacco Use. For the 21 participants 
who completed the interview, 71.4% (n=15) described themselves in ways consistent 
with being a current smoker or other tobacco user. For example, one participant stated, 
“Even everything I went through, I still smoke” (114). Similarly, another participant 
remarked, “I don’t enjoy it per se, but it’s relaxing to me…and to a degree it’s more 
stressful, ‘cause you know, I know the risk that I’m taking. I know what I’m doing to my 
body” (153), and still another said, “I still smoke every now and again. It’s a stress 
reliever for me” (148). A small number of participants reported use of another tobacco 
product in combination with, or instead of, conventional cigarettes. For example, “I 
started using…the electronic, and I do use that, like, twice a month” (100). The remaining 
participants (28.6%, n=6) described themselves as former smokers: “It was such a 
freedom to and relief to be finally free from that” (108); “The big part of why I did 
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recover is because I stopped smoking” (149); and “I’m an ex-smoker” (113). As a whole, 
the prevalence of continued tobacco use among cervical cancer survivors who were 
smokers at diagnosis was comparable across the questionnaire and interview data. 
Motivation and Confidence to Quit or Abstain from Smoking. Across the total sample, 
intention and confidence to quit/abstain in the next month were both low (M, SD=4.3, 3.9 
and 4.3, 4.0, respectively, both on a 0-10 scale). These variables were positively 
correlated with each other at the sample level: r=0.52, p<0.001. There was a significant 
difference (t (47) =3.10, p=.003) between the level of intention to quit among current 
smokers (M, SD=3.5, 3.2) and the level of intention to maintain abstinence among former 
smokers (M, SD=7.3, 4.7), such that a more favorable response was found among former 
smokers. Similarly, the level of confidence to quit among current smokers (M, SD=2.7, 
3.1) and the level of confidence to maintain abstinence among former smokers (M, 
SD=9.8, 0.6) differed significantly from each one another and suggested that former 
smokers were more confident: t (47) =7.6, p=.000. 
Quitting Preferences and Behavior. Across the sample, the majority of participants 
indicated a desire to quit smoking without the help of professionals (64.0%, n=32) or 
medications like NRT, Zyban, or Bupropion (58.0%, n=29); options mutually exclusive. 
Most current smokers (61.5%, n=24) preferred to quit without professional help but were 
nearly evenly divided on whether they wanted to quit without the aid of medication 
(51.3%, n=20); options mutually exclusive. In comparison, former smokers 
overwhelmingly preferred to quit without either professional help (72.7%, n=8) or 
medication (81.8%, n=9), perhaps a testament to the approach that yielded their current 
state of abstinence from smoking. 
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A lifetime history of serious quit attempts (defined as any 24-hour quit attempts) was 
high for the total sample (90.0%, n=45). Post-cancer diagnosis, 60.0% (n=30) of the 
sample reported having made at least one 24-hour quit attempt, which reflects 61.5% 
(n=24) of current smokers and all former smokers (n=11). The average number of 24-
hour quit attempts post-cancer diagnosis was 2.7 (SD=3.8; range: 0-20) at the sample 
level, 2.8 (SD=4.2; range: 0-10) for current smokers, and 1.8 (SD=1.2; range: 1-4) for 
former smokers. Former smokers reported having been abstinent from smoking, on 
average, for over a year (M=469.7±388.5 days), although half quit in the year (36.4%, 
n=4) or month (9.1%, n=1) before questionnaire completion.  Some current smokers 
reported making 24-hour quit attempts in the past year (51.3%, n=20), and among those 
who tried to quit, the average number of attempts was 1.96 (SD=1.9; range: 1-8). 
Details about participants’ treatment use can be found in Table 4 and is summarized here. 
Within the total sample, 60.0% (n=30) indicated ever having used an evidence-based 
treatment for smoking cessation (e.g., nicotine replacement therapy, quit line). This 
utilization rate corresponds to 64.1% (n=25) of current smokers and 45.5% (n=5) of 
former smokers. As indicated above, half of the former smokers quit more than a year 
prior to study participation; thus, more details about treatment utilization will be reserved 
for current smokers. Eighty percent (n=16) of current smokers who tried to quit in the last 
year reported doing so with the help of an evidence-based cessation treatment. In the 
context of these current smokers’ quit attempts (n=16), these treatments were utilized: 
50.0% physician consultation (n=10); 95.0% nicotine replacement therapy (n=19); 25.0% 
Chantix (n=4); and 12.5% Bupropion (n=2); options not mutually exclusive. 
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Aim 2. Association between Causal Attributions and Smoking Behavior 
For the questionnaire data, a chi-square analysis of independence was used to explore the 
association between causal attributions and smoking status. This analysis indicated 68.4% 
(n=26) of current smokers compared 50% (n=6) of former smokers agreed that smoking 
increases the risk of cancer in general. This difference in global attributions did not yield 
a statistically significant result: 2(1)= 1.34, p=0.25. A parallel analysis of personal 
attributions indicated that 26.3% (n=10) of current smokers as opposed to 33.3% (n=4) of 
former smokers agreed that their smoking contributed to their cancer. Again, the group 
difference was not statistically significant: 2(1)= 0.22, p=0.64. Additionally, a 
Spearman’s rank-order analysis (rho) was run to assess the relationship between 
participants’ causal attributions and intention to quit/abstain from smoking. The results of 
this analysis demonstrated a small, positive association for global attributions (rho=0.27, 
p=0.06) and a weaker, but still positive association for personal attributions (rho=0.12, 
p=0.42), neither of which was statistically significant. 
From the interview data, a clearer pattern was evident, such that current smokers 
admitted the harms of smoking, but generally minimized its contribution to their cancer 
diagnosis while former smokers were more inclined to admit the harms in general and the 
personal impact on their health and wellbeing. To summarize, almost without exception, 
all participants endorsed some degree of belief that smoking has a long-lasting, negative 
impact on overall health and health-related quality of life, which was in contrast to 
comparably low participant endorsement of the role that smoking has in cervical cancer 
specifically. As illustrated above in both the questionnaire and interview data, many 
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participants endorsed global causal attributions for cervical cancer or cancer at other sites 
while few reported personal causal attributions. 
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Table 2 
Demographic characteristics of cervical cancer survivors (N=50) 
Variable % (n) 
Age in years 1 45.53  8.08 
Race 
Caucasian, non-Hispanic 94.0 (47) 
African American 6.0 (3) 
Relationship status 
Single: never married 14.0 (7) 
Single: divorced, separated, or 
widowed  
38.0 (19) 
Married or partnered 46.0 (23) 
Missing 2.0 (1) 
Educational attainment 
Less than high school graduation 38.0 (19) 
High school graduate or equivalent 18.0  (9) 
Some college or technical school 36.0 (18) 
College or technical school graduate 8.0 (4) 
Employment 
Employed 36.0 (18) 
Unemployed 64.0 (32) 
Disabled 34.0 (17) 
Unemployed  1 year 16.0 (8) 
Unemployed < 1 year   4.0 (2) 
Homemaker   8.0 (4) 
Retired   2.0 (1) 
Geographic residence 
Urban or suburban 36.0 (18) 
Rural 60.0 (30) 
Missing 4.0 (2) 
Appalachian residence 
Yes 35.8 (19) 
No 64.2 (34) 
Annual household income 
Less than $10,000 24.0 (12) 
$10,000 to $19,999 30.0 (15) 
$20,000 to $34,999 14.0 (7) 
$35,000 to $49,999 10.0 (5) 
$50,000 to $74,999 6.0 (3) 
$75,000 or more 10.0 (5) 
Missing 6.0 (3) 
Note. Data are % (n) unless otherwise noted. 1 Data are means ± standard deviations. 
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Table 3 
Clinical characteristics of cervical cancer survivors (N=50) 
Variable Percent 
Years since diagnosis 1 2.70  1.28 
Months since treatment 1 31.41  15.64 
Age at diagnosis 42.78 7.96 
Cancer site 
Cervical 98.0 (49) 
Other 2.0 (1) 
Cancer stage 
I 56.0 (28) 
II 20.0 (10) 
III 22.0 (11) 
IV or metastatic 2.0 (1) 
Treatment type 
Surgery only 32.0 (16) 
Radiation only 2.0 (1) 
Radiation and chemotherapy 28.0 (14) 
Surgery and radiation 2.0 (1) 
Surgery, radiation, and chemotherapy 30.0 (15) 
Other 6.0 (3) 
Recurrence status 
No 68.0 (34) 
Yes 6.0 (3) 
Never disease-free 24.0 (12) 
Missing 2.0 (1) 
Insurance status 
Not insured 6.0 (3) 
Insured Private 34.0 (17) 
Tricare 2.0 (1) 
Medicaid 48.0 (24) 
Medicare 2.0 (1) 
        Insured other 8.0 (4) 
Note. Data are % (n) unless otherwise noted.  1 Data are means ± standard deviations. 
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Table 4 
Lifetime use of smoking cessation treatment (N=50) 
Prevalence (%) by smoking status 
Sample Current Former 
(N=50) (n=38) (n=12) 
Any treatment 92.0 68.4 41.7 
NRT medications 1
Patch, gum or lozenge 54.0 63.2 25.0 
Nasal spray or inhaler 10.0 13.2   0.0 
Non-NRT medications 1
Varenicline 30.0 31.6 25.0 
Bupropion 18.0 21.1   8.3 
Behavioral treatments 1
Quitline counseling 14.0 15.8    8.3 
Other counseling   8.0 10.5    0.0 
      Physician consult 50.0 52.6 41.7 
Note. NRT= Nicotine Replacement Therapy; 1 Options not mutually exclusive 
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Figure 1 
Study Flow Chart. 
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Chapter Four: Discussion 
Cervical cancer is undeniably and predominately associated with HPV infection 
(Schiffman et al., 2007; Waggoner, 2003), but research has also demonstrated causal 
links between smoking and cervical cancer (Coker, DeSimone, Bush, et al., 2009; Mayer 
& Carlson, 2011; Plummer et al., 2003). Smoking after cervical cancer diagnosis, as is 
the case with any cancer diagnosis, is a major health threat – one that has potential to 
shorten cancer survivors’ lives (US Department of Health and Human Services, 2014). 
For this reason, there is both a research and clinical imperative to identify risk and 
protective factors for smoking among cancer survivors, and to deliver evidence-based 
interventions for smoking cessation to all persistent smokers (Chuang et al., 2016; 
Emmons, Sprunck-Harrild, Puleo, & de Moor, 2013; NCCN, 2018). Despite strong 
theoretical and conceptual models that tie causal attributions to adjustment, motivation, 
and behavior change after major life events or stressors (Ajzen, 1991; Ajzen & Fishbein, 
1980; Heider, 1958; Hochbaum, 1958; McBride et al., 2003; Weiner, 1985), this variable 
has not received much attention in prior studies of smoking among cancer survivors. 
Nonetheless, smoking-related causal attributions of cancer may help to explain why 
changes in smoking behavior do or do not occur after cervical cancer diagnosis. 
There is clear consensus among cancer researchers and clinicians about what tends to 
cause or heighten risk for cancer, but the same cannot be said for cancer survivors 
(Weinstein et al., 2005; Wold et al., 2005). For individuals with a personal cancer history, 
the cause of their particular disease may be unclear, and this ambiguity leaves open the 
door for causal attributions that may or may not involve personal responsibility. For 
example, a cervical cancer survivor might attribute her cancer to fate, genetics, familial 
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risk, HPV, smoking, some combination thereof, or none of the above. Indeed, previous 
studies of causal attributions among cancer survivors have found a wide diversity of 
opinion as to what causes cancer in general and what caused their cancer specifically 
(Ferrucci et al., 2011; Liang et al., 2009; Lykins et al., 2008; Mullens et al., 2003; 
Rodriguez et al., 2015; Torre et al., 2015; Wold et al., 2005). Of particular interest here 
were the smoking-related beliefs held by cervical cancer survivors who admitted smoking 
at the time of their diagnosis, with the idea being that this group might be more inclined 
than the general population of cervical cancer survivors to associate smoking with 
cervical cancer on both global and personal levels, ultimately raising the possibility of a 
new target for smoking cessation interventions. 
The first major study finding is that the majority of the sample agreed that the risk of 
developing cervical cancer in general was higher among smokers than non-smokers. In 
other words, cervical cancer survivors tended to endorse global attributions, something 
that was evident in both questionnaire data and interview findings. The second major 
finding stands in direct contrast to the first, as far fewer participants agreed that their 
cervical cancer was caused by or associated with their smoking, again with consistency 
across questionnaire and interview responses. Altogether, what this means is that only a 
minority of cervical cancer survivors who endorsed global attributions responded in a 
way that also suggested a personal attribution. Prior research that explores cervical cancer 
survivors’ beliefs about smoking as a causal factor of cervical cancer in general has found 
results similar to those discussed here for global attributions (Costanzo et al., 2005; 
Lindau et al., 2002; Sherman, Lane, Sherman, & Lane, 2015). In addition, of the few 
prior studies of personal attributions, cervical cancer survivors were more inclined to 
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perceive their diagnosis as the result of HPV infection or an act of God, rather than as a 
result of tobacco use (Costanzo et al., 2005; Sterba et al., 2014), which also mirrors the 
findings in this study. This congruence in findings between current and past research on 
the topic exist despite the fact that prior studies recruited participants with varying 
smoking histories whereas this study focused exclusively on smokers at diagnosis. 
Overall, it appears there is a clear disconnect between the global and personal smoking-
related causal attributions made by cervical cancer survivors. 
As a whole, the causal attribution study findings suggest cervical cancer survivors may 
not have a full understanding of or appreciation for the role of smoking in cervical cancer 
risk (or prognosis). This is highlighted by the fact that interview participants frequently 
made mention of the strong, positive link between smoking and cancer in general as well 
as lung and head/neck cancers specifically, with fewer or weaker comments on the link 
between smoking and cervical cancer. Similar results of inexact knowledge or 
misunderstanding of smoking-related cancers are documented in other tobacco-related 
cancer samples, but most of this work is limited to lung and head/neck cancer 
(Christensen et al., 1999; Salander, 2007). The results of data analysis pertinent to the 
second study aim point toward a positive, albeit possibly weak, association between 
causal attributions and current smoking status and intentions to abstain in the future. 
Preliminary findings from the questionnaire responses are indicative of some knowledge, 
but not strong support, of smoking-related causal beliefs. Interview data further illustrates 
this, as there was a clear difference in causal attribution endorsement among former 
versus current smokers. Beyond cancer samples, similar knowledge and attribution trends 
exist in HIV/AIDS patients who continue to smoke after diagnosis despite warnings of 
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poor immune response (Shuter et al., 2017) and long-term drinkers who continue to 
consume alcohol in excess despite warnings of poor health (Cotter, Perez, Dunlop, Kite, 
& Gaskin, 2013). As a whole, this body of research underscores the role that causal 
attributions play in health behavior performance and change across disease populations. 
With a focus on the apparent discrepancy between global and personal attributions, a 
grim interpretation of the findings would indicate that the prevailing education-related 
cancer prevention and control efforts are inadequate, but that is likely too simplistic of an 
explanation. At least two other explanations exist. First, it is still common for cancer 
survivors to encounter disease-related stigma, particularly with cancer types typically 
associated with one’s own behavior (e.g., lung cancer and smoking, cervical cancer and 
sexually transmitted diseases) (Brown, Brodsky, & Cataldo, 2014; Hamann, Shen, 
Thomas, Lee, & Ostroff, 2017; Lebel et al., 2013; Lebel & Devins, 2008; Luberto, 
Hyland, Streck, Temel, & Park, 2016). For those who do perceive cancer-related stigma, 
other negative social and personal outcomes can co-occur, including the experience of 
social constraints and feelings of embarrassment and shame (Chambers et al., 2015; Else-
Quest & Jackson, 2014; Hamann et al., 2014; Hamann, Ver Hoeve, Carter-Harris, Studts, 
& Ostroff, 2018; Lebel et al., 2013; LoConte et al., 2008; Marlow, Waller, & Wardle, 
2010). For cancer survivors who smoke, the source of stigma could be twofold, as it 
could stem from the cancer diagnosis itself and others’ perception that the disease was 
self-induced or within the survivor’s control (Else-Quest & Jackson, 2014; Else-Quest, 
LoConte, Schiller, & Hyde, 2009; Weiner, 1993). The experience of stigma and 
associated negative outcomes may prompt some cancer survivors to adopt a defensive 
coping strategy such as minimizing the contribution that their behavior may have played 
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in their cancer and instead espousing alternative cancer attributions (Malcarne, Compas, 
Epping-Jordan, & Howell, 1995; McBride et al., 2003; A. Price et al., 2012). In sum, the 
perception of and response to stigma could help explain why cervical cancer survivors in 
this study tended to endorse global, but not personal smoking-related causal attributions. 
Second, fatalistic beliefs (i.e., a perception that life/health events are out of one’s own 
control and unavoidable) in general or about cancer specifically also might explain the 
relatively low endorsement of personal attributions in this study, as they are commonly 
cited in other studies with cancer survivors (Befort, Nazir, Engelman, & Choi, 2013; 
Costanzo et al., 2005; Lykins et al., 2008; McBride & Ostroff, 2003; Rodriguez et al., 
2015; Sterba et al., 2014). Regardless of the reason, if cervical cancer survivors disregard, 
minimize, or are unaware of the causal association between smoking and cervical cancer, 
it is likely they will not perceive continued smoking as an ongoing health risk, and as a 
result, their smoking behavior may not change. 
This brings up the third major finding of this study, which is that the rate of current 
smoking in this sample (80%) is higher than what is already documented for cervical 
cancer survivors (typically, 40-50%) (Brinton et al., 1986; CDC, 2018; Coker, 
DeSimone, Eggleston, et al., 2009; Coups & Ostroff, 2005; Marteau et al., 2002; Mayer 
& Carlson, 2011; Plummer et al., 2003; Roura et al., 2014; Schlumbrecht, Sun, Huang, 
Zandstra, & Bodurka, 2014b) plus the rates found amongst other smoking-related cancer 
survivors (Berg, Carpenter, Jardin, & Ostroff, 2013; Burris, Studts, De Rosa, & Ostroff, 
2015; Coups & Ostroff, 2005), as well recent estimates of smoking in the general 
population of US women (14%) (CDC, 2015). However, two important methodological 
differences exist across these studies/estimates. First, other samples reflect greater 
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heterogeneity in terms of their sociodemographic and geographic composition whereas 
this sample is largely comprised of socioeconomically disadvantaged women who live in 
rural areas. Second, most other studies survey cancer survivors in general and do not 
report prevalence rates for current smoking by smoking history at diagnosis (i.e., never, 
former, or current) (Brown et al., 2014; Burris, Studts, et al., 2015; Land et al., 2016; 
Mayer & Carlson, 2011) while this study targeted cancer survivors who were current 
smokers at diagnosis. Remarkably, this study aimed first to enroll women of low 
socioeconomic status, as the burden of cervical cancer is greatest in this population 
(Akinlotan et al., 2017; Hopenhayn et al., 2008) and the generalizability of the findings 
are therefore more pronounced, and second to enroll women at greatest risk for continued 
smoking (Burris, Studts, et al., 2015), as the resultant findings were thought to be critical 
to development of more effective smoking cessation interventions for cancer survivors as 
a whole (Nayan, Gupta, Strychowsky, & Sommer, 2013). Nonetheless, this sampling 
strategy led to a sample of cervical cancer survivors that is potentially at heightened risk 
for smoking after cancer diagnosis. 
Closely considering the smoking and quitting behavior of cervical cancer survivors in this 
study, several findings warrant comment. First, among current smokers, nicotine 
dependence in the sample was moderate, as indicated by the typical time to first cigarette 
(i.e., within 30 minutes of waking) and average number of cigarettes per day (i.e., 
roughly ¾ of a pack). Prior research demonstrates that factors related to smoking 
cessation in the general population also hold true in cancer populations (e.g., the role of 
motivation and confidence in quit attempts (Biener & Hargraves, 2015; Burris et al., 
2016; Schnoll et al., 2013), so it remains imperative to address nicotine dependence, 
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withdrawal, craving and the like in any smoking cessation intervention for cancer 
survivors (Cooley et al., 2013; Ostroff et al., 2014; S. Price et al., 2017). Second, nearly 
half of current smokers reported “dual use,” that is the use of conventional cigarettes 
alongside either e-cigarettes or cigars. Interestingly, former smokers reported lifetime, 
but not current, use of an alternative tobacco product, suggesting an encouraging trend of 
total product cessation and abstinence. A paucity of studies has explored alternative 
tobacco product use in cancer survivors (for exceptions, see (Berg et al., 2013; Borderud, 
Li, Burkhalter, Sheffer, & Ostroff, 2014), but the current study suggests it may be 
important to do so in the future. Third, a majority of the total sample reported at least one 
lifetime quit attempt, with more than half (60%) attempting cessation after diagnosis. 
Despite low direct endorsement of smoking-related causal attributions in the sample, this 
finding may demonstrate a more generic association between cancer diagnosis and 
smoking behavior. Fourth, regarding treatment use, former smokers mostly quit 
unassisted and supported a “cold turkey” approach, while current smokers expressed 
more openness to help with smoking cessation, which may be a function of their 
frustration with “failed” quit attempts. Prior research has found few cancer survivors seek 
help with smoking cessation (Dahm et al., 2009; Medbø, Melbye, & Rudebeck, 2011; 
Miele et al., 2018; Morphett, Partridge, Gartner, Carter, & Hall, 2015; Schnoll et al., 
2013), so it is encouraging that many of the current smokers who recently made quit 
attempts opted to use nicotine replacement or another evidence-based treatment. That 
said, most of the cervical cancer survivors in this study are burdened by low 
socioeconomic status, which may negatively impact their long-term access to high-
quality and timely healthcare, inclusive of smoking cessation treatments (Cooper, 
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Borland, & Yong, 2011; Kruger et al., 2012). Fifth, the high rate of current smoking may 
be the result of the unfortunate combination of low motivation and confidence to quit, 
making it important to highlight that there exist proven interventions to boost smokers’ 
motivation and confidence to quit (Burris, Heckman, Mathew, & Carpenter, 2015; 
Hettema & Hendricks, 2010; Lundahl et al., 2013). Given all of the above, there seems to 
exist great need for targeted, if not tailored, interventions for cervical cancer survivors 
who smoke. 
The methodological strengths and weaknesses of this mixed-method pilot study deserve 
comment. First and foremost, this study is the first to describe the smoking behaviors of 
cervical cancer survivors in any detail, which is a necessary first step toward 
development of tailored interventions for this high-risk group of cancer survivors. Prior 
tobacco use studies in this population generally provide point prevalence estimates of 
smoking with little or no comment on product type(s), frequency, quantity, or nicotine 
dependency, and only limited information about quit attempt history (Hopenhayn, 
Christian, Christian, Studts, & Mullet, 2013; Schlumbrecht et al., 2014b). Given that 
prior US population-based studies show cervical cancer survivors to smoke at a rate that 
exceeds both women in the general population and other cancer survivor groups (Iyer et 
al., 2016; Shoemaker, White, Hawkins, & Hayes, 2016; Underwood et al., 2012), it is 
important to understand their unique smoking and quitting experience. Second, cervical 
cancer survivors – which represent an understudied population – are typically considered 
vulnerable and hard-to-reach (Freeman & Wingrove, 2005; Nayan et al., 2013). 
Consequently, the recruitment efforts of this study, which included partnering with a 
community-based organization that serves under-insured and poor cancer survivors, is a 
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strength as it allowed the enrollment of women who truly reflect the larger population of 
interest. Finally, and related to the above point, this study utilized a combination of 
population-based and purposive recruitment strategies in an attempt to obtain a 
representative sample. 
Of course, this study is not without limitations. The first limitation is the size of the 
sample and the fact that it is homogenous in terms of demographic variables of race and 
ethnicity. These two factors likely limit generalizability of the findings to Caucasian, 
non-Hispanic women, which is an important consideration given that nationwide, cervical 
cancer is more common among women of African American and Hispanic heritage (U.S. 
Cancer Statistics Working Group, 2015) . That said, the sample is representative of the 
state from which it was drawn (Kentucky Cancer Registry, 2017), which is largely white 
and non-Hispanic. Second, at the point of contact by the two recruitment sources, the 
rates of acceptance for study interest were modest (34-50%). This might be due to the 
manner in which research procedures, costs, and benefits were described by the two 
recruitment sources, but by and large, the overall accrual rate is consistent with prior 
studies that used state registries to identify participants (Burris & Andrykowski, 2010; 
Coker, DeSimone, Eggleston, et al., 2009; Keegan et al., 2013; Vadaparampil et al., 
2012). Furthermore, the rates of acceptance for study participation once eligibility was 
determined by study personnel was very high (91-92%), which speaks to the feasibility of 
accrual once the population is identified. A third limitation is reliance on self-report for 
smoking and other tobacco use status, as this study did not use biochemical verification 
to confirm reports of abstinence. However, smoking rates in the sample were so high that 
there is little reason to believe that participants misrepresented their tobacco use 
38
behaviors. Furthermore, this approach is not without precedent in other observational 
studies with cancer survivors (Glasgow et al., 1993; Studts et al., 2006; Wong, Shields, 
Leatherdale, Malaison, & Hammond, 2012). Fourth, given that some participants were 
asked to reflect upon and report their experiences and behavior in the five years before 
data collection (i.e., from diagnosis to date), some of the results are subject to 
retrospective bias. However, the primary outcomes of interest (i.e., causal attributions and 
current smoking behaviors) were present-focused outcomes. Finally, not all 50 
participants chose to complete an interview, and the findings of the 21 who did may or 
may not be representative of the full sample or of all cervical cancer survivors. Therefore, 
it is important to note that post hoc analyses that compared interview and non-interview 
participants on all demographic and clinical variables (as well as the prevalence of 
current smoking) yielded no significant differences between groups (data not shown), 
suggesting that at least within the sample herein, the findings likely generalize. In 
conclusion, despite its limitations, this study is a significant contribution to the sparse 
literature on causal attributions and smoking behaviors of cervical and potentially other 
smoking-related cancer survivors. 
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